<bill session="116" type="s" number="3049" updated="2022-10-28T01:45:57Z">
  <state datetime="2019-12-12">REFERRED</state>
  <status>
    <introduced datetime="2019-12-12"/>
  </status>
  <introduced datetime="2019-12-12"/>
  <titles>
    <title type="display">LAB Act</title>
    <title type="short" as="introduced">LAB Act</title>
    <title type="short" as="introduced">Laboratory Access for Beneficiaries Act</title>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to provide for certain amendments relating to reporting requirements with respect to clinical diagnostic laboratory tests, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="B000944"/>
  <cosponsors>
    <cosponsor bioguide_id="B001267" joined="2019-12-16"/>
    <cosponsor bioguide_id="B001135" joined="2019-12-12"/>
    <cosponsor bioguide_id="M000639" joined="2019-12-16"/>
    <cosponsor bioguide_id="R000307" joined="2019-12-16"/>
    <cosponsor bioguide_id="T000476" joined="2019-12-16"/>
  </cosponsors>
  <actions>
    <action datetime="2019-12-12">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-12-12" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="1865" relation="unknown"/>
    <bill session="116" type="h" number="3584" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Health information and medical records"/>
    <term name="Inflation and prices"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2020-10-09T13:16:42Z" status="Introduced in Senate">Laboratory Access for Beneficiaries Act or the LAB Act

This bill revises the periods during which laboratories must report clinical diagnostic test information to the Centers for Medicare &amp; Medicaid Services for purposes of determining Medicare payment rates. Additionally, the Medicare Payment Advisory Commission must evaluate the methodology used to determine a specified laboratory fee schedule.</summary>
</bill>
